Clinical Trial

Article on Secretin clinical trial for Autism

By |2016-10-05T06:46:13-04:00June 27th, 2008|Categories: Autism, Medication, Research|Tags: , , , , , , , , , |

In 2003, we were a site that participated in conducting a clinical trial for Secretin. The purpose of the study was to determine safety and efficacy of Secretin versus placebo in the treatment of Autism symptoms.  Unfortunately, the study results found that there was no difference in symptom change between children on Secretin and those on placebo.   Here's an article on [...]

Comments Off on Article on Secretin clinical trial for Autism

New data on ADHD study drug NS2359

By |2016-10-05T06:46:13-04:00June 25th, 2008|Categories: ADHD, Medication, Research|Tags: , , , , , , , |

NS2359 is a mixed monoamine reuptake inhibitor.  A study looked at the efficacy of NS2359 versus placebo in a double-blind randomized trial. There was no statistical difference in the total ADHD-RS scale score between those taking NS2359 and placebo.  However, when looking at the inattentive type of ADHD, 41% of those who took NS2359 had an [...]

Comments Off on New data on ADHD study drug NS2359
Go to Top